These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 22445057)
1. Ramadan fasting and diabetes: an observational study among Turkish migrants in Belgium. Peeters B; Mehuys E; Van Tongelen I; Van Bever E; Bultereys L; Avonts D; Yıldız G; Remon JP; Boussery K Prim Care Diabetes; 2012 Dec; 6(4):293-6. PubMed ID: 22445057 [TBL] [Abstract][Full Text] [Related]
2. [Diabetes and fasting during Ramadan. A observational study among Turkish immigrants in Belgium]. Peeters B; Mehuys E; Van Tongelen I; Van Bever E; Bultereys L; Avonts D; Yildiz G; Remon JP; Boussery K J Pharm Belg; 2013 Mar; (1):12-6. PubMed ID: 23638607 [TBL] [Abstract][Full Text] [Related]
3. Understanding medication adherence among patients of Turkish descent with type 2 diabetes: a qualitative study. Peeters B; Van Tongelen I; Duran Z; Yüksel G; Mehuys E; Willems S; Remon JP; Boussery K Ethn Health; 2015; 20(1):87-105. PubMed ID: 24588791 [TBL] [Abstract][Full Text] [Related]
4. Ramadan fasting in diabetes patients on insulin pump therapy augmented by continuous glucose monitoring: an observational real-life study. Khalil AB; Beshyah SA; Abu Awad SM; Benbarka MM; Haddad M; Al-Hassan D; Kahwatih M; Nagelkerke N Diabetes Technol Ther; 2012 Sep; 14(9):813-8. PubMed ID: 22827507 [TBL] [Abstract][Full Text] [Related]
5. A double-blind, randomized trial, including frequent patient-physician contacts and Ramadan-focused advice, assessing vildagliptin and gliclazide in patients with type 2 diabetes fasting during Ramadan: the STEADFAST study. Hassanein M; Abdallah K; Schweizer A Vasc Health Risk Manag; 2014; 10():319-26. PubMed ID: 24920915 [TBL] [Abstract][Full Text] [Related]
6. [Recommendations for the management of diabetes during Ramadan]. Peeters B; Mehuys E; Boussery K J Pharm Belg; 2013 Mar; (1):18-9. PubMed ID: 23638608 [No Abstract] [Full Text] [Related]
7. Comparison of analog insulin mix 50:50 with human insulin mix 30:70 in persons with type 2 diabetes during Ramadan. Hajjaji IM; Eshwihdi N; Barrowman N Int J Clin Pract; 2019 Jun; 73(6):e13348. PubMed ID: 30912213 [TBL] [Abstract][Full Text] [Related]
8. An update on the current characteristics and status of care for Muslims with type 2 diabetes fasting during Ramadan: the DAR global survey 2022. Hassanein M; Binte Zainudin S; Shaikh S; Shaltout I; Malek R; Buyukbese MA; Alfadhli EM; Shaikh K; Hussein Z; Eliana F; Hafidh K; El Toony LF; Fariduddin M; Alabbood M; Batais MA; Akter N; Rosandi R; Odhaib SA; Al Amoudi R; Ahmedani MY Curr Med Res Opin; 2024 Sep; 40(9):1515-1523. PubMed ID: 39076065 [TBL] [Abstract][Full Text] [Related]
9. Ramadan Perspective Epidemiology and Education in Diabetes (RAPEED) Study. Siddiqui NI; Kamrul-Hasan M; Hossain MA; Chanda PK; Bakar MA; Rahman M; Kader MA Mymensingh Med J; 2017 Apr; 26(2):256-265. PubMed ID: 28588159 [TBL] [Abstract][Full Text] [Related]
10. Comparison of Humalog Mix 50 with human insulin Mix 30 in type 2 diabetes patients during Ramadan. Hui E; Bravis V; Salih S; Hassanein M; Devendra D Int J Clin Pract; 2010 Jul; 64(8):1095-9. PubMed ID: 20337752 [TBL] [Abstract][Full Text] [Related]
11. Vildagliptin therapy and hypoglycaemia in Muslim type 2 diabetes patients during Ramadan. Devendra D; Gohel B; Bravis V; Hui E; Salih S; Mehar S; Hassanein M Int J Clin Pract; 2009 Oct; 63(10):1446-50. PubMed ID: 19678856 [TBL] [Abstract][Full Text] [Related]
12. Impact of provision of optimum diabetes care on the safety of fasting in Ramadan in adult and adolescent patients with type 1 diabetes mellitus. Alawadi F; Alsaeed M; Bachet F; Bashier A; Abdulla K; Abuelkheir S; Rashid F; Abdulaziz Bin Hussain A; Abdelgadir E; Alsayyah F; Elsayed M; Hassanein M Diabetes Res Clin Pract; 2020 Nov; 169():108466. PubMed ID: 32971155 [TBL] [Abstract][Full Text] [Related]
13. Attitude and safety of patients with diabetes observing the Ramadan fast. Ba-Essa EM; Hassanein M; Abdulrhman S; Alkhalifa M; Alsafar Z Diabetes Res Clin Pract; 2019 Jun; 152():177-182. PubMed ID: 30946851 [TBL] [Abstract][Full Text] [Related]
14. Safety and metabolic impact of Ramadan fasting in children and adolescents with type 1 diabetes. El-Hawary A; Salem N; Elsharkawy A; Metwali A; Wafa A; Chalaby N; El-Gilany A; Abo-Elmagd M; El-Ziny M J Pediatr Endocrinol Metab; 2016 May; 29(5):533-41. PubMed ID: 26926864 [TBL] [Abstract][Full Text] [Related]
15. Metabolic alterations as a result of Ramadan fasting in non-insulin-dependent diabetes mellitus patients in relation to food intake. Khatib FA; Shafagoj YA Saudi Med J; 2004 Dec; 25(12):1858-63. PubMed ID: 15711655 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of insulin glargine and glimepiride in subjects with Type 2 diabetes before, during and after the period of fasting in Ramadan. Salti I; Diabet Med; 2009 Dec; 26(12):1255-61. PubMed ID: 20002478 [TBL] [Abstract][Full Text] [Related]
17. Suggested insulin regimens for patients with type 1 diabetes mellitus who wish to fast during the month of Ramadan. Kobeissy A; Zantout MS; Azar ST Clin Ther; 2008 Aug; 30(8):1408-15. PubMed ID: 18803984 [TBL] [Abstract][Full Text] [Related]
18. Correlation between pre-ramadan glycemic control and subsequent glucose fluctuation during fasting in adolescents with Type 1 diabetes. Afandi B; Kaplan W; Al Hassani N; Hadi S; Mohamed A J Endocrinol Invest; 2017 Jul; 40(7):741-744. PubMed ID: 28239763 [TBL] [Abstract][Full Text] [Related]
19. Repaglinide plus single-dose insulin glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan. Bakiner O; Ertorer ME; Bozkirli E; Tutuncu NB; Demirag NG Acta Diabetol; 2009 Mar; 46(1):63-5. PubMed ID: 18825302 [TBL] [Abstract][Full Text] [Related]
20. [Migration and diabetes (Update 2019)]. Aydinkoc-Tuzcu K; Schindler K; Sat S; Berger F; Ludvik B; Fasching P Wien Klin Wochenschr; 2019 May; 131(Suppl 1):229-235. PubMed ID: 30980158 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]